Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis CouncilCapsule Summary

Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis CouncilCapsule Summary

Background: As biosimilars have become available in various parts of the world, the International Psoriasis Council has reviewed aspects of their use. Objective: To provide consensus statements from the Biosimilar Working Group about the use of biosimilars in patients with psoriasis. Methods: A semi...

Description complète

Détails bibliographiques
Auteurs principaux: Arnon D. Cohen, MD, MPH, PhD, Ronald Vender, MD, FRCPC, Luigi Naldi, MD, Robert E. Kalb, MD, Tiago Torres, MD, PhD, Murlidhar Rajagopalan, MD, Joelle van der Walt, PhD, Lluís Puig, MD (Hon), PhD, Helen S. Young, MB ChB, PhD, FRCP
Format: Article
Langue:English
Publié: Elsevier 2020-12-01
Collection:JAAD International
Sujets:
biosimilars
interchangeability
International Psoriasis Council
psoriasis
switching
tumor necrosis factor inhibitors
Accès en ligne:http://www.sciencedirect.com/science/article/pii/S2666328720300523

Documents similaires

Documents similaires